Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with or Mutation
Introduction EGFR and KRAS mutations are frequently detected in lung adenocarcinoma (LUAD). Tumor mutational signature (TMS) determination is an approach to identify somatic mutational patterns associated with pathogenic factors. In this study, through the analysis of TMS, the underlying pathogenic...
Saved in:
Main Authors: | Jialiang Wang MM, Chang Guo BMed, Jiexiao Wang MM, Xiaopeng Zhang BS, Jian Qi PhD, Xiang Huang MM, Zongtao Hu MM, Hongzhi Wang MM, Bo Hong PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/10732748241307363 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Economic Status on Cause-Specific Survival in Patients with Esophageal Adenocarcinoma in the United States: A Retrospective Analysis
by: Xiu-Shun Xiang MM, et al.
Published: (2024-11-01) -
Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma
by: Ruolan Zhang M.M., et al.
Published: (2024-12-01) -
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
by: Yuji Uehara, MD, et al.
Published: (2025-03-01) -
Intra- and Peritumoral-Based Radiomics for Preoperatively Assessing the Pathological Subtype of T1-Stage Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules
by: Wenting Jiang BM, et al.
Published: (2024-12-01) -
EGFR-Mutated Lung Adenocarcinoma With Li–Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case Report
by: Hiroyuki Fujii, MD, et al.
Published: (2025-02-01)